BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
87 hedge funds and large institutions have $187M invested in BioSpecifics Technologies Corp. in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 29 increasing their positions, 35 reducing their positions, and 9 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
3% less funds holding
Funds holding: 90 → 87 (-3)
6% less capital invested
Capital invested by funds: $199M → $187M (-$11.3M)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
17% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$7.25M |
| 2 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
+$1.25M |
| 3 |
ECP
Elk Creek Partners
Denver,
Colorado
|
+$1.18M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.18M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$929K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$2.64M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.85M |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$1.65M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$1.4M |
| 5 |
ADEF
Adams Diversified Equity Fund
Baltimore,
Maryland
|
-$619K |
BSTC Hedge Fund Activity: Q3 2017 in Review
87 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q3 2017, worth a combined $187M — down 5.7% from $199M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of BSTC and 8 opened new positions — a net loss of 1 holder — while 35 trimmed existing stakes and 29 added.
The largest buyer was Stonepine Capital Management, adding an estimated $7.25M. The largest seller was Numeric Investors, cutting an estimated $2.64M.
- 87 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q3 2017, down from 90 in Q2 2017.
- Funds reported $187M of BioSpecifics Technologies Corp. stock for Q3 2017, down 5.7% quarter-over-quarter.
- 8 funds opened new BioSpecifics Technologies Corp. positions in Q3 2017 and 9 closed out, a net change of -1 holder.
- The largest BioSpecifics Technologies Corp. buyer in Q3 2017 was Stonepine Capital Management, an estimated $7.25M added.
- The largest BioSpecifics Technologies Corp. seller in Q3 2017 was Numeric Investors, an estimated $2.64M sold.
Based on aggregated 13F filings for Q3 2017.